Keywords
Last Name

Sashidhar Nakerakanti

TitlePostdoctoral Fellow
InstitutionBoston University Medical Campus
DepartmentRheumatology
Address72 E. Concord St Evans Building
Boston MA 02118
Phone(617) 638-6821
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Rice LM, Padilla CM, McLaughlin SR, Mathes A, Ziemek J, Goummih S, Nakerakanti S, York M, Farina G, Whitfield ML, Spiera RF, Christmann RB, Gordon JK, Weinberg J, Simms RW, Lafyatis R. Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients. J Clin Invest. 2015 Jul 1; 125(7):2795-807. PMID: 26098215.
    View in: PubMed
  2. Stifano G, Affandi AJ, Mathes AL, Rice LM, Nakerakanti S, Nazari B, Lee J, Christmann RB, Lafyatis R. Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis. Arthritis Res Ther. 2014; 16(4):R136. PMID: 24984848.
    View in: PubMed
  3. Nakerakanti S, Trojanowska M. The Role of TGF-ß Receptors in Fibrosis. Open Rheumatol J. 2012; 6:156-62. PMID: 22802914.
    View in: PubMed
  4. Nakerakanti SS, Bujor AM, Trojanowska M. CCN2 is required for the TGF-ß induced activation of Smad1-Erk1/2 signaling network. PLoS One. 2011; 6(7):e21911. PMID: 21760921.
    View in: PubMed
  5. Hattori T, Stawski L, Nakerakanti SS, Trojanowska M. Fli1 is a negative regulator of estrogen receptor a in dermal fibroblasts. J Invest Dermatol. 2011 Jul; 131(7):1469-76. PMID: 21451544.
    View in: PubMed
  6. Markiewicz M, Nakerakanti SS, Kapanadze B, Ghatnekar A, Trojanowska M. Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells. Microcirculation. 2011 Jan; 18(1):1-11. PMID: 21166920.
    View in: PubMed
  7. Samuel GH, Bujor AM, Nakerakanti SS, Hant FN, Trojanowska M. Autocrine transforming growth factor ß signaling regulates extracellular signal-regulated kinase 1/2 phosphorylation via modulation of protein phosphatase 2A expression in scleroderma fibroblasts. Fibrogenesis Tissue Repair. 2010; 3:25. PMID: 21134273.
    View in: PubMed
  8. Wang B, Carter RE, Jaffa MA, Nakerakanti S, Lackland D, Lopes-Virella M, Trojanowska M, Luttrell LM, Jaffa AA. Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetes. J Med Genet. 2010 Jun; 47(6):391-7. PMID: 20522428.
    View in: PubMed
  9. Bujor AM, Nakerakanti S, Morris E, Hant FN, Trojanowska M. Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts. Exp Dermatol. 2010 Apr; 19(4):347-54. PMID: 20201953.
    View in: PubMed
  10. Pannu J, Asano Y, Nakerakanti S, Smith E, Jablonska S, Blaszczyk M, ten Dijke P, Trojanowska M. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate. Arthritis Rheum. 2008 Aug; 58(8):2528-37. PMID: 18668566.
    View in: PubMed
  11. Pannu J, Nakerakanti S, Smith E, ten Dijke P, Trojanowska M. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J Biol Chem. 2007 Apr 6; 282(14):10405-13. PMID: 17317656.
    View in: PubMed
  12. Nakerakanti SS, Kapanadze B, Yamasaki M, Markiewicz M, Trojanowska M. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. J Biol Chem. 2006 Sep 1; 281(35):25259-69. PMID: 16829517.
    View in: PubMed
Sashidhar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department